Study of Idarubicin, Cytarabine, and Nivolumab in Patients With High-Risk Myelodysplastic Syndrome (MDS) and Acute Myeloid Leukemia (AML)
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Roswell Park Cancer Institute
Stanford University
Case Comprehensive Cancer Center
Masonic Cancer Center, University of Minnesota
OHSU Knight Cancer Institute